Status:
UNKNOWN
Assessment of Nanocrystalline Hydroxyapatite Versus Autogenous Bone Grafts : A Comparative Clinical Study in Alveolar Cleft Grafting
Lead Sponsor:
Assiut University
Conditions:
Alveolar Cleft
Eligibility:
All Genders
7-12 years
Phase:
NA
Brief Summary
This work aims to evaluate Nanocrystalline Hydroxyapatite versus Autogenous bone grafts in alveolar cleft grafting
Detailed Description
Alveolar cleft is the most common congenital bone defect. Since its introduction in 1972, alveolar bone grafting (ABG) has been widely accepted to correct alveolar bone defect in most cleft centres.Th...
Eligibility Criteria
Inclusion
- Age (7 - 12 years )
- Non-syndromic CLA or CLP
- More than 6 months of follow-up
Exclusion
- History of previous alveolar surgery
- History of active infection or underlying disease such as hematologic disorders , neoplasm, and immune deficiency
- Patients who had received primary or tertiary ABG
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04693559
Start Date
January 1 2021
End Date
March 1 2023
Last Update
January 5 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.